Cargando…
Long-term outcomes after NeuroCOVID: A 6-month follow-up study on 60 patients
BACKGROUND AND PURPOSE: Long-term outcomes after neurological manifestations due to COVID-19 are poorly known. The aim of our study was to evaluate the functional outcome and identify the risk factors of neurologic sequelae after COVID-19 associated with neurological manifestations (NeuroCOVID). MET...
Autores principales: | Chaumont, H., Meppiel, E., Roze, E., Tressières, B., de Broucker, T., Lannuzel, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753577/ https://www.ncbi.nlm.nih.gov/pubmed/35000793 http://dx.doi.org/10.1016/j.neurol.2021.12.008 |
Ejemplares similares
-
Manifestations neurologiques associées à l’infection SARS-CoV-2 : le registre français NeuroCOVID
por: Meppiel, E., et al.
Publicado: (2020) -
NeuroCOVID: it's time to join forces globally
por: Helbok, Raimund, et al.
Publicado: (2020) -
NeuroCOVID-19: a critical review
por: Guedes, Bruno Fukelmann
Publicado: (2022) -
Cerebrospinal fluid biomarkers in SARS-CoV-2 patients with acute neurological syndromes
por: Chaumont, H., et al.
Publicado: (2023) -
NeuroCOVID: critical review of neuropsychiatric manifestations of SARS-CoV-2 infection
por: Oliveira, Renato, et al.
Publicado: (2020)